News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
582,884 Results
Type
Article (19133)
Company Profile (167)
Press Release (563580)
Multimedia
Podcasts (79)
Webinars (13)
Section
Business (198471)
Career Advice (702)
Deals (30759)
Drug Delivery (92)
Drug Development (65676)
Employer Resources (55)
FDA (12417)
Job Trends (11112)
News (287979)
Policy (24151)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (832)
Accelerated approval (46)
ADA (26)
Adcomms (10)
Allergies (146)
Alliances (41824)
ALS (146)
Alzheimer's disease (1284)
Antibody-drug conjugate (ADC) (368)
Approvals (13081)
Artificial intelligence (528)
ASCO (219)
Autoimmune disease (264)
Automation (42)
Bankruptcy (321)
Best Places to Work (8369)
BIO (47)
Biologics (9)
BIOSECURE Act (10)
Biosimilars (197)
BioSpace Insights (77)
Biotechnology (102)
Bladder cancer (156)
Brain cancer (58)
Breast cancer (614)
Cancer (4583)
Cardiovascular disease (369)
Career advice (607)
Career pathing (15)
CAR-T (223)
CDC (8)
CDMO (64)
Celiac Disease (2)
Cell therapy (621)
Cervical cancer (42)
Clinical research (59059)
Collaboration (1766)
Commercialization (6)
Company closure (3)
Compensation (1546)
Complete response letters (61)
COVID-19 (1289)
CRISPR (84)
C-suite (1121)
Cystic fibrosis (128)
Data (6844)
Decentralized trials (1)
Denatured (23)
Depression (126)
Dermatology (75)
Diabetes (451)
Diagnostics (4857)
Digital health (46)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (279)
Drug pricing (128)
Drug shortages (15)
Duchenne muscular dystrophy (233)
Earnings (81460)
Editorial (25)
Employer branding (5)
Employer resources (51)
Events (99746)
Executive appointments (982)
FDA (15676)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (20)
Frontotemporal dementia (29)
Funding (1262)
Gene editing (166)
Generative AI (36)
Gene therapy (474)
GLP-1 (682)
Government (2019)
Grass and pollen (5)
Guidances (332)
Healthcare (11101)
Hematology (128)
HIV (56)
Huntington's disease (28)
IgA nephropathy (102)
Immunology and inflammation (173)
Immuno-oncology (84)
Indications (198)
Infectious disease (1525)
Inflammatory bowel disease (174)
Inflation Reduction Act (9)
Influenza (98)
Intellectual property (303)
Interviews (93)
IPO (13980)
IRA (33)
Job creations (3111)
Job search strategy (550)
JPM (29)
Kidney cancer (20)
Labor market (42)
Layoffs (255)
Leadership (11)
Legal (6582)
Licensing (22)
Liver cancer (56)
Longevity (26)
Lung cancer (653)
Lymphoma (351)
Machine learning (35)
Management (19)
Manufacturing (957)
Marketing (12)
MASH (166)
Medical affairs (3)
Medical device (9290)
Medtech (9454)
Mergers & acquisitions (17982)
Metabolic disorders (1086)
mRNA (117)
Multiple sclerosis (143)
NASH (15)
Neurodegenerative disease (305)
Neuropsychiatric disorders (74)
Neuroscience (2479)
Neurotech (1)
NextGen: Class of 2026 (3899)
Non-profit (1261)
Now hiring (24)
Obesity (434)
Opinion (158)
Ovarian cancer (178)
Pain (255)
Pancreatic cancer (236)
Parkinson's disease (283)
Partnered (21)
Patents (603)
Patient recruitment (620)
Patient selection (1)
Peanut (39)
People (50836)
Peptides (2)
Pharmaceutical (45)
Pharmacy benefit managers (24)
Phase 1 (18202)
Phase 2 (25955)
Phase 3 (19295)
Pipeline (9138)
Policy (167)
Postmarket research (2127)
Preclinical (7550)
Press Release (49)
Prostate cancer (240)
Psychedelics (31)
Radiopharmaceuticals (279)
Rare diseases (878)
Real estate (4473)
Recruiting (20)
Regulatory (19883)
Reports (30)
Research institute (965)
Resumes & cover letters (94)
Rett syndrome (43)
RNA editing (12)
RSV (53)
Schizophrenia (150)
Series A (228)
Series B (158)
Service/supplier (5)
Sickle cell disease (98)
Special edition (11)
Spinal muscular atrophy (114)
Sponsored (16)
Startups (2788)
State (2)
Stomach cancer (9)
Supply chain (97)
Tariffs (71)
The Weekly (54)
Vaccines (527)
Venture capital (59)
Weight loss (229)
Women's health (106)
Worklife (4)
Date
Today (65)
Last 7 days (462)
Last 30 days (1780)
Last 365 days (23132)
2026 (16314)
2025 (23308)
2024 (27256)
2023 (31391)
2022 (40755)
2021 (43364)
2020 (39877)
2019 (29702)
2018 (22639)
2017 (24696)
2016 (23547)
2015 (29442)
2014 (25683)
2013 (22079)
2012 (24101)
2011 (24442)
2010 (23671)
Location
Africa (467)
Alabama (84)
Alaska (2)
Arizona (342)
Arkansas (13)
Asia (30260)
Australia (4165)
California (12995)
Canada (3539)
China (1082)
Colorado (518)
Connecticut (483)
Delaware (280)
Europe (54855)
Florida (1990)
Georgia (421)
Hawaii (3)
Idaho (49)
Illinois (879)
India (103)
Indiana (566)
Iowa (17)
Japan (581)
Kansas (120)
Kentucky (39)
Louisiana (32)
Maine (28)
Maryland (1396)
Massachusetts (8922)
Michigan (330)
Minnesota (613)
Mississippi (5)
Missouri (106)
Montana (27)
Nebraska (16)
Nevada (121)
New Hampshire (68)
New Jersey (3265)
New Mexico (18)
New York (3176)
North Carolina (1565)
North Dakota (4)
Northern California (6535)
Ohio (317)
Oklahoma (17)
Oregon (29)
Pennsylvania (2450)
Puerto Rico (26)
Rhode Island (36)
South America (732)
South Carolina (81)
South Dakota (1)
Southern California (5361)
Tennessee (150)
Texas (2089)
United States (43946)
Utah (393)
Vermont (1)
Virginia (276)
Washington D.C. (51)
Washington State (1014)
West Virginia (2)
Wisconsin (109)
Wyoming (2)
582,884 Results for "wex pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Wex Pharmaceuticals Inc. Commences Its Quantitative Sensory Testing Clinical Trial Evaluating the Impact of Halneuron(R) on Healthy Volunteers’ Sensory Perceptions
WEX Pharmaceuticals Inc. (“WEX” or the “Company”), a biotechnology company developing Halneuron® (Tetrodotoxin or TTX) for pain, announced that it has commenced its Quantitative Sensory Testing (QST) clinical trial and is actively recruiting participants into this clinical trial.
December 11, 2023
·
5 min read
Press Releases
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
August 5, 2026
·
3 min read
Press Releases
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
October 8, 2024
·
14 min read
Press Releases
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
June 28, 2026
·
5 min read
Press Releases
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update
August 14, 2026
·
12 min read
Press Releases
ConV2X Releases Final Agenda Focused on AI, Clinical Development, FDA Regulation and Pharmaceutical Data Integrity
ConV2X Releases Final Agenda Focused on AI, Clinical Development, FDA Regulation and Pharmaceutical Data Integrity
September 8, 2026
·
1 min read
Press Releases
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
August 16, 2026
·
15 min read
Press Releases
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
July 15, 2026
·
2 min read
Press Releases
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules
July 30, 2026
·
6 min read
Press Releases
/UPDATE -- Seismic Pharmaceuticals/
September 9, 2026
·
4 min read
1 of 58,289
Next
